ÂÜÀòÂÒÂ×

Benjamin Hall is a Senior Scientist in Analytical Development at Tessera Therapeutics, where responsibilities include leading the development of potency assays for drug substances and products in an in vivo gene rewriting program, mentoring junior scientists, and collaborating on regulatory strategies. Previous experience includes roles at 2seventy bio, where Benjamin contributed to immune cell-based assays for drug characterization, and at bluebird bio, focused on T cell analytics and lentiviral vector characterization. Benjamin's early career involved research roles in proteomics and patient care, complemented by a robust educational background in Biology, Environmental Studies, and Mathematics from Boston College, with ongoing studies at Harvard Extension School.